Compare TTEC & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTEC | ACB |
|---|---|---|
| Founded | 1982 | 2013 |
| Country | United States | Canada |
| Employees | 69400 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 232.3M |
| IPO Year | 1996 | 2016 |
| Metric | TTEC | ACB |
|---|---|---|
| Price | $1.22 | $4.16 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 330.6K | ★ 889.1K |
| Earning Date | 05-07-2026 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,509,171,000.00 | N/A |
| Revenue This Year | N/A | $6.31 |
| Revenue Next Year | $0.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $1.18 | $2.56 |
| 52 Week High | $3.99 | $6.67 |
| Indicator | TTEC | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 32.47 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $2.49 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 24.39 | 0.00 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.